India Specialty Chemicals Stocks FY26: ROCE & Margins Ranked

India's specialty chemicals sector is in the middle of a bifurcation. The companies that chose fluorochemicals, CDMO agrochemical custom synthesis, and performance fluoropolymers — rather than commodity intermediates — are reporting returns on capital that are among the highest in Indian manufacturing. The companies that leaned into commodity volumes are grappling with pricing cycles and compressed margins. The divergence in FY26 ROCE data is striking: the top performer (Navin Fluorine) earns 21% ROCE; the bottom (Aarti Industries) earns just 7% ROCE — from the same broadly defined sector.

We pulled live FY26 annual data from DocStoX (sourced from NSE/BSE audited annual filings) for five of India's most widely tracked specialty chemicals stocks and ranked them by ROCE and ROE — the two metrics that determine whether a capital-intensive chemical business is creating or consuming shareholder value. These are audited annual (FY26) figures, not TTM estimates or broker projections.

Why ROCE Is the Right Lens for Specialty Chemicals

Specialty chemicals businesses require sustained fixed-asset investment — reactors, distillation columns, effluent treatment plants, clean-room API synthesis suites. A company earning 7% ROCE is barely covering its weighted average cost of capital; at 21% ROCE, a company is compounding surplus capital that funds the next capacity cycle without diluting shareholders. In a sector where the China+1 opportunity is real but uneven — and where the companies that invest in fluorination, cGMP agrochemical synthesis, and high-purity intermediates are winning a disproportionate share of global business — ROCE separates the structural winners from the cyclical commodity players.

FY26 ROCE Scoreboard: The Rankings (Data as of July 9, 2026)

All figures sourced from NSE/BSE audited annual filings via DocStoX data:

• Navin Fluorine (NAVINFLUOR): 21% ROCE — highest in the group; 20.3% ROE; PE 59.39x
• PI Industries (PIIND): 15% ROCE — near-debt-free (D/E 0.03); PAT ₹1,321 Cr
• SRF Ltd (SRF): 15% ROCE — largest by market cap; PAT ₹1,835 Cr; PE 44.53x
• Deepak Nitrite (DEEPAKNTR): 11% ROCE — commodity-cycle headwinds; PE 40.17x
• Aarti Industries (AARTIIND): 7% ROCE — lowest returns; ROE 7.13%; high leverage (D/E 0.83)

Navin Fluorine (NAVINFLUOR): Sector Leader at 21% ROCE, 20.3% ROE

Navin Fluorine International is India's fluorochemicals specialist — a company that has systematically moved up the value chain from basic HF chemistry to cryogenic fluorination, high-performance fluoropolymers (HPPO), and CDMO fluorochemicals for agrochemicals and pharma innovators. The FY26 numbers reflect that positioning. ROCE of 21% and ROE of 20.3% are the highest in this five-stock group and rank among the top-quartile returns in all of Indian chemicals manufacturing.

PAT of ₹664 crore on market cap of approximately ₹0.39 lakh crore gives a PAT yield of roughly 1.7% — modest, which is why the market prices NAVINFLUOR at a P/E of 59.39x. D/E of 0.32 reflects measured leverage to fund the Dahej HPPO plant expansion and CDMO capacity. EPS of ₹129.46 at the current price of ₹7,689 confirms the premium the market places on fluorochemicals scarcity and CDMO optionality. The 59x PE is expensive in absolute terms; it is justifiable only if the CDMO ramp (fluorination for global innovator agrochemicals and pharma molecules) continues to compound PAT at double-digit rates. P/B of 9.74x tells the same story — investors are paying nearly 10x book for a business they believe will earn well above cost of capital for a long time.

PI Industries (PIIND): Near-Debt-Free Agrochemical CDMO at 15% ROCE

PI Industries is India's premier agrochemical CDMO and branded-formulation company — and it runs one of the cleanest balance sheets in the sector. D/E of just 0.03 makes PI Industries virtually debt-free: a ₹39,414-crore-market-cap company carrying less than 3 paise of debt per rupee of equity. ROCE of 15% and ROE of 11.6% are solid for a company that funds its own growth from operating cash flow with minimal external capital. PAT of ₹1,321 crore is the second-highest in this group.

The business model is structurally defensive: PI's CDMO agrochemical order book is multi-year (5-7 year commercial supply agreements with global innovators), non-cyclical in demand, and high-margin relative to generic agrochemical formulators. The domestic branded business (Osheen, Nominee Gold) adds volume stability. At a P/E of 29.84x and P/B of 3.52x, PI Industries is the most reasonably valued quality name in this group — not cheap, but priced without the CDMO-scarcity premium that inflates NAVINFLUOR's 59x multiple. EPS of ₹87.06 at ₹2,597.5 per share.

SRF Ltd (SRF): Largest Market Cap, Diversified — 15% ROCE, ₹1,835 Cr PAT

SRF is the most diversified company in this analysis — spanning fluorochemicals (refrigerants + specialty fluorochemicals), packaging films (BOPP/BOPET/BOPP), technical textiles (belting fabrics, industrial yarn), and agrochemicals. Its PAT of ₹1,835 crore is the highest in this group — reflecting scale advantages across its multi-business model. ROCE of 15% and ROE of 14.3% are respectable for a conglomerate with heavy capital investment in films capacity and fluorochemicals plants.

Market cap of approximately ₹0.82 lakh crore makes SRF the sector leader by size — larger than NAVINFLUOR and PI Industries combined. At P/E 44.53x and P/B 5.91x, the market is pricing in SRF's proven ability to generate returns across cycles in both fluorochemicals and packaging films. D/E of 0.36 is manageable. The risk: SRF's earnings are more exposed to packaging-film pricing cycles and refrigerant gas pricing than the pure-play CDMO names. In an upcycle across both films and fluorochemicals (which FY27 projections point toward), SRF's PAT scale is its key advantage. In a downcycle, diversification cuts both ways.

Deepak Nitrite (DEEPAKNTR): Commodity Cycle Pressure at 11% ROCE

Deepak Nitrite is India's largest bulk organic intermediate manufacturer — nitro-toluenes, nitro-chlorobenzenes, sodium nitrite/nitrate, and the phenolics complex at Dahej (phenol, acetone, isopropyl alcohol). These are high-volume, moderate-margin intermediates that are exposed to crude/benzene pricing and global supply-demand cycles. The FY26 numbers reflect that exposure. ROCE of 11% and ROE of 9.97% — the lowest in this group excluding Aarti — reflect compressed margins as the phenolics cycle has been weak. PAT of ₹551 crore at market cap ₹22,123 crore gives a PE of 40.17x — a multiple that looks expensive for an 11% ROCE business but prices in the recovery optionality as phenolics margins normalise.

D/E of 0.28 is comfortable. EPS of ₹40.36 at ₹1,621.2 per share. The investment case for Deepak Nitrite in 2026 is a cycle-recovery thesis: phenol/acetone margins were depressed through FY25-26 by Chinese oversupply; any supply rationalisation or tariff action in petrochemicals would disproportionately benefit Deepak given its integrated benzene-to-phenol complex. But at 40x PE with 11% ROCE, the recovery is not yet visible in the trailing numbers, and the multiple demands execution.

Aarti Industries (AARTIIND): Highest Leverage, Lowest Returns

Aarti Industries is the most challenged name in this group on return metrics. ROCE of 7% and ROE of 7.13% are below most estimates of cost of capital for an Indian chemical company — meaning Aarti is currently earning less than it costs to fund its assets. PAT of ₹419 crore at PE of 40.48x implies the market expects a material PAT recovery. D/E of 0.83 is the highest in the group — Aarti has been investing heavily in specialty chemicals capacity (chlorotoluene, sulphuric acid, ATBS monomers) and the expansion cycle has compressed near-term returns.

Market cap of approximately ₹0.17 lakh crore. EPS of ₹11.56 at ₹467.95 per share. The bull case for Aarti is that the capacity additions are largely complete and as utilisation rises, ROCE should recover toward the sector average (15%) within 2-3 years. The bear case: with 0.83x D/E and below-WACC returns in the interim, the capital efficiency recovery is not guaranteed, and any macro headwind to speciality chemical demand (particularly from global dye and agrochemical customers) delays the recovery timeline. Of the five stocks, Aarti carries the most balance-sheet risk in a stress scenario.

FY26 Full Scoreboard: All Five Stocks

All figures from NSE/BSE audited annual filings (FY26, March 2026 period), sourced via DocStoX data:

• Navin Fluorine (NAVINFLUOR): PAT ₹664 Cr | ROE 20.3% | ROCE 21% | P/E 59.39x | D/E 0.32 | Mkt Cap ~₹0.39 lakh Cr
• PI Industries (PIIND): PAT ₹1,321 Cr | ROE 11.6% | ROCE 15% | P/E 29.84x | D/E 0.03 | Mkt Cap ~₹0.39 lakh Cr
• SRF Ltd (SRF): PAT ₹1,835 Cr | ROE 14.3% | ROCE 15% | P/E 44.53x | D/E 0.36 | Mkt Cap ~₹0.82 lakh Cr
• Deepak Nitrite (DEEPAKNTR): PAT ₹551 Cr | ROE 9.97% | ROCE 11% | P/E 40.17x | D/E 0.28 | Mkt Cap ~₹0.22 lakh Cr
• Aarti Industries (AARTIIND): PAT ₹419 Cr | ROE 7.13% | ROCE 7% | P/E 40.48x | D/E 0.83 | Mkt Cap ~₹0.17 lakh Cr

Three Structural Themes for India Specialty Chemicals in FY27

1. China+1 fluorochemicals: Global agrochemical and pharma innovators are actively qualifying Indian fluorination capacity as a strategic alternative to Chinese supply. NAVINFLUOR and SRF's specialty fluorochemicals businesses are the primary beneficiaries. Any new CDMO contract announcements in H1 FY27 are material for both stocks.
2. Agrochemical CDMO order book build: PI Industries' multi-year commercial order pipeline (disclosed at ₹8,500+ crore in recent calls) provides multi-year revenue visibility. The critical metric to watch: commercial-scale ramp of new molecules from the pipeline (which contribute higher margins than regular supply).
3. Phenolics and commodity cycle recovery: Deepak Nitrite and Aarti Industries are leveraged to a normalisation of phenol/acetone margins and specialty chemical demand from the dye and agrochemical customer base. If Chinese phenol capacity utilisation stays elevated, recovery is delayed. If anti-dumping measures are applied or demand picks up in H2 FY27, both stocks have meaningful earnings-upgrade potential from depressed FY26 bases.

The DocStoX Take

India's specialty chemicals sector in FY26 splits into three clear quality tiers:

Quality at a premium (NAVINFLUOR): 21% ROCE, 20.3% ROE, 59x PE. The best capital returns in the group, priced for sustained CDMO and fluorochemicals growth. Expensive, but rare asset quality in Indian chemicals.

Quality at a fair price (PI Industries, SRF): Both at 15% ROCE, with PI Industries carrying a near-zero-debt balance sheet (D/E 0.03) and SRF offering the highest absolute PAT (₹1,835 Cr) at a more reasonable 44.5x PE given its scale and diversification. PI Industries at 29.84x PE is the most attractively priced high-quality name in this group.

Cycle recovery bets (Deepak Nitrite, Aarti Industries): Both trading at 40x PE with single-digit to low-double-digit ROCE — multiples that discount a recovery in commodity intermediate pricing and capacity utilisation that has not yet arrived in FY26 audited numbers. Higher risk, higher upside if the recovery materialises; meaningful downside if it is delayed further.

For investors screening India specialty chemicals stocks 2026 on a fundamentals-first basis, NAVINFLUOR's ROCE leadership and PI Industries' near-debt-free quality-at-fair-value positioning are the two standout data points this analysis surfaces. Full live DocStoX AI verdicts, fair-value estimates, and financials for all five companies are available at docstox.com.

---

By the DocStoX Desk — This is for informational purposes only and not investment advice. Please consult a SEBI-registered advisor before investing.